Te Ahumairangi Investment Management Ltd Makes New Investment in Cigna Group $CI

Te Ahumairangi Investment Management Ltd bought a new position in Cigna Group (NYSE:CI) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 19,223 shares of the health services provider’s stock, valued at approximately $5,299,000.

Other large investors also recently made changes to their positions in the company. GQG Partners LLC bought a new stake in Cigna Group in the 2nd quarter worth about $1,628,918,000. Norges Bank purchased a new position in shares of Cigna Group in the 4th quarter worth approximately $1,019,790,000. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Cigna Group by 13,333.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock valued at $900,912,000 after acquiring an additional 3,141,844 shares in the last quarter. Dodge & Cox increased its position in shares of Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after acquiring an additional 1,833,389 shares during the last quarter. Finally, Boston Partners lifted its holdings in Cigna Group by 314.6% during the fourth quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock worth $450,856,000 after acquiring an additional 1,243,056 shares during the period. 86.99% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the company. Guggenheim raised their target price on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Mizuho raised their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Wall Street Zen lowered shares of Cigna Group from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a research report on Monday, June 1st. Finally, Barclays raised their price target on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $339.45.

Insider Transactions at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Nicole S. Jones sold 2,677 shares of the company’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 23,012 shares of company stock worth $6,386,550 in the last 90 days. Company insiders own 0.60% of the company’s stock.

Cigna Group Trading Down 0.5%

Shares of CI stock opened at $276.19 on Monday. The company’s fifty day simple moving average is $284.20 and its two-hundred day simple moving average is $281.45. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47. The stock has a market capitalization of $72.98 billion, a price-to-earnings ratio of 11.43, a PEG ratio of 0.95 and a beta of 0.29.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period last year, the company earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, analysts anticipate that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 25.82%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.